Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudeep Gupta

Showing results (1-10 of 347) with videos related to

Pageof 35
Sort By:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Progression-free or overall survival…revisited in BOLERO-2Sudeep Gupta
Nature Clinical Practice. Oncology|March 28, 2008
HER2 positivity predicts a benefit from paclitaxel treatment after adjuvant chemotherapySudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|September 15, 2010
Biological reasoning…and statistics…Sudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 24, 2013
Triple negative breast cancer: A continuing challengeSudeep Gupta
Nature Clinical Practice. Oncology|November 3, 2005
Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?Sudeep Gupta
The Indian Journal of Medical Research|February 23, 2024
Navigating cancer care in India: Reflections & imperativesSudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|January 6, 2011
Of teachers and students…Sudeep Gupta
Journal of Gynecologic Oncology|May 30, 2019
Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbrokenSudeep Gupta
South Asian Journal of Cancer|September 9, 2016
Breast cancer: Indian experience, data, and evidenceSudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|May 18, 2011
Progression-free or overall… That is the question…Sudeep Gupta
Pageof 35

Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Progression-free or overall survival…revisited in BOLERO-2Sudeep Gupta
Nature Clinical Practice. Oncology|March 28, 2008
HER2 positivity predicts a benefit from paclitaxel treatment after adjuvant chemotherapySudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|September 15, 2010
Biological reasoning…and statistics…Sudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 24, 2013
Triple negative breast cancer: A continuing challengeSudeep Gupta
Nature Clinical Practice. Oncology|November 3, 2005
Should paclitaxel be combined with epirubicin or carboplatin as first-line chemotherapy for advanced breast cancer?Sudeep Gupta
The Indian Journal of Medical Research|February 23, 2024
Navigating cancer care in India: Reflections & imperativesSudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|January 6, 2011
Of teachers and students…Sudeep Gupta
Journal of Gynecologic Oncology|May 30, 2019
Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbrokenSudeep Gupta
South Asian Journal of Cancer|September 9, 2016
Breast cancer: Indian experience, data, and evidenceSudeep Gupta
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|May 18, 2011
Progression-free or overall… That is the question…Sudeep Gupta
Pageof 35